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Four new organotin(IV) complexes of the type [MeSnCl(dact)] (2), [BuSnCl(dact)] (3), [PhSnCl(dact)] (4)
and [Ph2Sn(dact)] (5) were synthesized by the direct reaction of 2-hydroxyacetophenone-N(4)-
cyclohexylthiosemicarbazone [H2dact, (1)] and organotin(IV) chloride(s) in absolute methanol. The
ligand [H2dact, (1)] and its organotin(IV) complexes (2–5) have been characterized by CHN analyses,
molar conductivity, UV–Vis, FT-IR, 1H, 13C and 119Sn NMR spectral studies. The molecular structure of
complex (5) has also been determined by single-crystal X-ray diffraction. The crystal structure of complex
(5) showed that the ligand is doubly deprotonated at the oxygen and sulfur atoms and is coordinated to
the tin(IV) atom through thiolate-S, azomethine-N and phenoxide-O atoms. X-ray diffraction studies
indicated that complex (5) is a monomer and the central tin(IV) atom is five coordinated in a distorted
trigonal bipyramidal geometry. The cytotoxicity of the ligand (1) as well as its organotin(IV) complexes
(2–5) was studied against Artemia salina. The in vitro antibacterial activities of these compounds were
also evaluated. The screening results have shown that the organotin(IV) complexes (2–5) have better
antibacterial activity than the free ligand. Furthermore, it has been shown that diphenyltin(IV) derivative
(5) exhibits significantly better activity than the monoorganotin(IV) derivatives (2–4).
 2012 Elsevier B.V. All rights reserved.1. Introduction
Thiosemicarbazones form an interesting class of compounds
with a wide range of pharmacological applications [1,2]. Thiosemi-
carbazone usually act as chelating ligand with certain metal ions,
bonding through the sulfur and hydrazine nitrogen atoms [3]. The
heterocyclic thiosemicarbazones are of high interest because of
their great versatility as ligands. This is due to the presence of
several potential donor atoms, their flexibility and ability to coordi-
nate either neutral or deprotonated forms. Seena and Kurup have
synthesized and characterized dioxomolybdenum(IV) complexes
with 2-hydroxyacetophenone-N(4)-cyclohexyl and N(4)-phenyl
thiosemicarbazone which suggested that the Mo(IV) complex is
penta-coordinated [4]. Rebolledo et al. have reported that Pd(II)
complexes of 2-benzoylpyridine-N(4)-methyl/phenyl thiosemicar-
bazone ligands are active against the MCF-7, TK-10 and UACC-62
human tumor cell line [5]. For the past few years, studies of the
coordination chemistry of thiosemicarbazone involved complexesll rights reserved.
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).with transition metal ions [6–9]. The synthesis and characterization
of organotin(IV) complexes of Schiff base ligands have always
attracted the attention of inorganic chemists and is well established
in the literature [10–14]. Organotin(IV) complexes have been
extensively studied due to their beneficial biological activities as
well as their wide industrial and agricultural applications [15–21].
de Sousa et al. have reported organotin(IV) derivatives of 2-
hydroxyacetophenone-N(4)-phenylthiosemicarbazone and found
that the Sn(IV) atom adopts a strongly distorted trigonal bipyrami-
dal configuration [22]. Although the organotin(IV) complexes
exhibit important cytotoxic effects, but based on the literature re-
view there is still very limited information available regarding the
X-ray and biological studies of novel organotin(IV) complexes with
substituted thiosemicarbazone ligands [23]. Previous works
described the synthesis and structural studies of tin(IV)/organo-
tin(IV) complexes with N(4)-substituted thiosemicarbazone ligand
[24,25]. The particular interest of this work is a better understand-
ing of the structural diversity of organotin(IV) complexes to
delineate their biological properties. This paper reports the
synthesis, spectral characterization and in vitro biological activity
of organotin(IV) complexes (2–5). X-ray crystal structure of
diphenyltin(IV) complex (5) is also described.
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2.1. Materials and methods
All reagents were purchased from Fluka, Aldrich and JT Baker.
All solvents were purified according to standard procedures [26].
The UV–Vis spectra were recorded with CHCl3 solvent on a
Perkin–Elmer Lambda 25 UV–Vis spectrophotometer. Infrared
spectra (IR) were recorded on KBr discs using a Perkin–Elmer Spec-
trum GX Fourier-Transform spectrometer (4000–375 cm1). 1H,
13C and 119Sn NMR spectra were recorded on a JEOL 500
MHz-NMR spectrometer; chemical shifts were given in ppm rela-
tive to SiMe4 and Me4Sn in CDCl3 solvent. Elemental analyses were
recorded with a Flash EA 1112 series CHN elemental analyzer.
Molar conductance values were measured with DMF solvent using
a Jenway 4510 conductivity meter. A colorless block crystal of
compound 5 was measured at 150 K on a CrysAlispro CCD
diffractometer with graphite monochromated MoKa radiation
(k = 0.7107). The structure was solved by direct methods using
SHELXL-97 and refined by full-matrix least-squares refinement on
F2 using SHELXL-97. Positional and anisotropic atomic displacement
parameters were refined for all non-hydrogen atoms. Hydrogen
atoms were placed in calculated positions.
2.2. Synthesis of N(4)-cyclohexylthiosemicarbazide
Cyclohexylisothiocyanate (1.41 g, 10 mmol) in 4 mL of ether
was added drop-wise into 4 mL of ether solution of hydrazine
hydrate (2 g, 40 mmol). The mixture was stirred vigorously for
5 h. Then, 5 mL petroleum ether was added into the resulting solu-
tion and stirred for another 1 h and white precipitate was formed.
The white precipitate was filtered, washed with a small amount of
cool diethyl ether and dried in vacuo over silica gel. Yield: 2.12 g,
62%: Mp.: 146–148 C: FT-IR (KBr disc, cm1) mmax: 3334 (s, NH2),
3297 (s, NH), 2929, 2853 (s, cyclohexyl), 1349, 849 (w, C@S).
2.3. Synthesis of 2-hydroxyacetophenone-N(4)-
cyclohexylthiosemicarbazone (H2dact) (1)
A solution of N(4)-cyclohexylthiosemicarbazide (0.51 g, 3 mmol)
in 10 mL absolute methanol was treated with 10 mL absolute meth-
anolic solution of 2-hydroxyacetophenone (0.408 g, 3 mmol). The
resulting reaction mixture was stirred and refluxed for 4 h (Scheme
1). On cooling the solution to room temperature light brownScheme 1. Synthesis of 2-hydroxyacetophenone-N(4)-microcrystals formed, filtered off and washed several times with
methanol. The light brown microcrystals were recrystallised from
methanol and dried in vacuo over silica gel. Yield: 0.76 g, 82%:
Mp.: 173–175 C: UV–Vis (CHCl3) kmax/nm: 262, 328, 361: FT-IR
(KBr disc, cm1) mmax: 3315 (s, OH), 3102 (s, NH), 2923, 2851 (s,
cyclohexyl), 1620 (m, C@N), 1296 (m, CAO), 987 (m, NAN), 1365,
840 (w, C@S). 1H NMR (CDCl3) d: 10.87 (s, 1H, OH), 8.79 (s, 1H,
N2AH), 8.35 (s, 1H, CyC1AH), 7.44–7.29 (m, 4H, phenyl ring), 2.35
(s, 3H, N@CACH3), 2.07–1.31 (m, 10H, CyCAH), 1.8 (s, 1H, SH). 13C
NMR (CDCl3) d: 184.99 (NHAC@S), 164.11 (C@N), 142.36–137.10
(aromatic ring), 48.83–32.61 (cyclohexyl ring), 8.99 (CH3). Anal.
Calc. for C15H21N3O1S1: C, 61.82; H, 7.26; N, 14.42. Found: C,
61.77; H, 7.21; N, 14.38%.
2.4. Synthesis of [MeSnCl(dact)] (2)
H2dact (0.291 g, 1.0 mmol) was dissolved in absolute methanol
(10 mL) in a Schlenk round bottom flask under a nitrogen
atmosphere. Then, a methanolic solution of methyltin(IV) trichlo-
ride (0.240 g, 1.0 mmol) was added drop wise. The resulting
reaction mixture was refluxed for 4 h (Scheme 2) and cooled to
room temperature. The microcrystals were filtered off, washed
with a small amount of cold methanol and dried in vacuo over silica
gel. Yield: 0.43 g, 80%: Mp.: 206–208 C: Molar conductance (DMF)
X1 cm2 mol1: 11.6: UV–Vis (CHCl3) kmax/nm: 269, 335, 385, 416:
FT-IR (KBr, cm1) mmax: 3103 (s, NH), 2920, 2850 (s, cyclohexyl),
1598 (m, C@NAN@C), 1266 (m, CAO), 1028 (w, NAN), 1322, 825
(m, CAS), 578 (w, SnAC), 543 (w, SnAO), 420 (w, SnAN). 1H NMR
(CDCl3, 2J[119Sn, 1H]) d: 8.78 (s, 1H, N2AH), 8.37 (s, 1H, CyC1AH),
7.43–7.26 (m, 4H, phenyl ring), 2.47 (s, 3H, N@CACH3), 2.09–1.28
(m, 10H, CyCAH), 1.07 (s, 3H, SnACH3), [79.1 Hz]. 13C NMR (CDCl3)
d: 181.65 (N@CAS), 170.22 (C@N), 140.38–136.50 (aromatic ring),
48.10–35.30 (cyclohexyl ring), 18.10 (CH3), 12.59 (SnACH3). 119Sn
NMR (CDCl3) d: 175.80. Anal. Calc. for C16H22N3SOSnCl: C,
41.90; H, 4.83; N, 9.16. Found: C, 41.88; H, 4.75; N, 9.09%.
The other complexes (3–5) were synthesized using a similar
procedure to the organotin(IV) complex (2) using appropriate
organotin(IV) chloride(s) (Scheme 2).
2.5. Synthesis of [BuSnCl(dact)] (3)
Yield: 0.45 g, 78%: Mp.: 202–204 C: molar conductance (DMF)
X1 cm2 mol1: 9.72: UV–Vis (CHCl3) kmax/nm: 265, 332, 385, 412:
FT-IR (KBr, cm1) mmax: 3105 (s, NH), 2925, 2853 (s, cyclohexyl),cyclohexylthiosemicarbazone (H2dact) ligand (1).
Scheme 2. The reaction scheme for the synthesis of organotin(IV) complexes (2–5).
M.A. Affan et al. / Inorganica Chimica Acta 387 (2012) 219–225 2211596 (m, C@NAN@C), 1268 (m, CAO), 1027 (w, NAN), 1325, 827
(m, CAS), 580 (w, SnAC), 538 (w, SnAO), 422 (w, SnAN). 1H NMR
(CDCl3) d: 8.77 (s, 1H, N2AH), 8.35 (s, 1H, CyC1AH), 7.43–7.25
(m, 4H, phenyl ring), 2.46 (s, 3H, N@CACH3), 2.07–1.79 (m, 10H,
CyCAH), 1.73–1.70 (t, 2H, SnACH2ACH2ACH2ACH3), 1.63–1.60
(m, 2H, SnACH2ACH2ACH2ACH3), 1.44–1.39 (m, 2H,
SnACH2ACH2ACH2ACH3), 0.93–0.90 (t, 3H, SnACH2ACH2ACH2A
CH3). 13C NMR (CDCl3) d: 179.22 (N@CAS), 168.55 (C@N),
141.87–136.43 (aromatic ring), 47.99–32.60 (cyclohexyl ring),
32.88, 26.32, 24.88, 20.73 (SnACH2ACH2ACH2ACH3), 16.50 (CH3).
119Sn NMR (CDCl3) d: 183.05. Anal. Calc. for C19H28N3SOSnCl: C,
45.58; H, 5.63; N, 8.39. Found: C, 45.53; H, 5.59; N, 8.36%.2.6. Synthesis of [PhSnCl(dact)] (4)
Yield: 0.47 g, 79%: Mp.: 212–214 C: molar conductance (DMF)
X1 cm2 mol1: 13.11: UV–Vis (CHCl3) kmax/nm: 265, 331, 386, 404;
FT-IR (KBr, cm1) mmax: 3104 (s, NH), 2924, 2851 (s, cyclohexyl),
1595 (m, C@NAN@C), 1261 (m, CAO), 1025 (w, NAN), 1328, 822
(m, CAS), 598 (w, SnAC), 531 (w, SnAO), 425 (w, SnAN). 1H NMR
(CDCl3) d: 8.74 (s, 1H, N2AH), 8.36 (s, 1H, CyC1AH), 7.43–7.27
(m, 9H, phenyl ring), 2.49 (s, 3H, N@CACH3), 2.07–1.42 (m, 10H,
CyCAH). 13C NMR (CDCl3) d: 180.77 (N@CAS), 174.45 (C@N),
140.11–138.23 (aromatic ring), 48.30–32.77 (cyclohexyl ring),
17.60 (CH3). 119Sn NMR (CDCl3) d: 188.92. Anal. Calc. for
C21H24N3SOSnCl: C, 48.44; H, 4.64; N, 8.07. Found: C, 48.40; H,
4.59; N, 8.02%.2.7. Synthesis of [Ph2Sn(dact)] (5)
Yield: 0.48 g, 75%: Mp.: 258–260 C: molar conductance (DMF)
X1 cm2 mol1: 8.17: UV–Vis (CHCl3) kmax/nm: 264, 350, 382, 408:
FT-IR (KBr, cm1) mmax: 3103 (s, NH), 2923, 2850 (s, cyclohexyl),
1598 (m, C@NAN@C), 1267 (m, CAO), 1021 (w, NAN), 1347, 822
(m, CAS), 600 (w, SnAC), 533 (w, SnAO), 447 (w, SnAN). 1H NMR
(CDCl3) d: 8.78 (s, 1H, N2AH), 8.39 (s, 1H, CyC1AH), 7.40–7.32
(m, 14H, phenyl ring), 2.51 (s, 3H, N@CACH3), 2.09–1.41 (m, 10H,
CyCAH). 13C NMR (CDCl3) d: 179.98 (N@CAS), 171.75 (C@N),
142.20–138.21 (aromatic ring), 50.48–32.83 (cyclohexyl ring),
15.88 (CH3). 119Sn NMR (CDCl3) d: 170.10. Anal. Calc. forC27H29N3SOSn: C, 57.67; H, 5.19; N, 7.47. Found: C, 57.61; H,
5.14; N, 7.43%.
2.8. Cytotoxicity
The substituted thiosemicarbazone ligand (1) and its organo-
tin(IV) complexes (2–5) were screened for toxicity using the pub-
lished method [27] with some modifications. A stock solution of
5000 ppm of the ligand [H2dact, (1)] and its organotin(IV) com-
plexes (2–5) were prepared in DMSO. Then, the stock solutions were
further diluted into seven different levels of dose and later topped
up to 5 mL; which were 1, 5, 10, 50, 100, 150 and 300 ppm. The
hatching process was carried out at ambient temperature for 24 h,
and a pinch of Artemia salina cysts was placed in a beaker with
100 mL treated sea water. During the hatching process, aeration
and light was provided at room temperature. After 24 h, the hatched
nauplii were attracted by the light source and tended to stay at the
surface of the sea water, while the shells and remaining cysts were
deposited at the bottom of the sea water. The shrimps were transfer
to fresh sea water in a Petri dish for ease of calculation. About 20 ac-
tive shrimps were added to 5 mL diluted test solution in each and
every plastic testing mug. After 24 h on incubation under direct
light at room temperature, the mortality of the shrimps in each
mug was counted. The mortality was computed and corrected for
the natural death observed in the negative control using Abbott’s
formula [27]. All results of the mortality were expressed in percent-
ages and plotted in an allosteric sigmoidal graph using a Graph pad
prism.
2.9. Antibacterial test
The antibacterial test of synthesized ligand (1) and its organo-
tin(IV) complexes (2–5) was carried out using the agar well
diffusion method [28]. Doxycycline was used as the standard drug.
The bacteria from stock culture were lightly inoculated into the
Mueller Hinton Broth (MHB) and allowed to grow overnight at
37 C in an ambient air incubator. The culture was diluted with a
new MHB in order to achieve an absorbance value of 2.0  106 col-
ony forming units (CFU/mL) or 0.168 at wavelength of 550 nm in
the spectrophotometer. Sterile cotton swab was dipped into the
broth culture and inoculated on the Mueller Hinton Agar (MHA).
Sterile paper discs with 6 mm diameter were placed on the agar
in equal distance. The recommended concentration of the test sam-
ple (2 mg/mL in DMSO) was introduced individually to each of the
discs. The agar plates were incubated immediately at 37 C for
20 h. For each plate, DMSO mixture and reference antibacterial
drug such as doxycycline served as negative and positive controls,
respectively. The activity was determined by measuring the
diameter of zones showing complete inhibition (mm). Growth
inhibition was calculated with reference to the positive control.3. Results and discussion
The ligand 2-hydroxyacetophenone-N(4)-cyclohexylthiosemic-
arbazone (H2dact) was prepared by the condensation reaction of
2-hydroxyacetophenone and N(4)-cyclohexylthiosemicarbazide.
The ligand (1) acts as dinegative tridentate ONS donors in this
work. It has two tautomers within the structure, existing as either
a thione or a thiol tautomer (Scheme 1). Four new organotin(IV)
complexes (2–5) were obtained in good yields by the equimolar
reaction of organotin(IV) salts with H2dact (1) (Scheme 2). The
physical and analytical data of 1–5 are given in the experimental
section. All organotin(IV) compounds were stable in N2 atmo-
sphere and soluble in common organic solvents. The molar
conductivity of the organotin(IV) complexes (2–5) in DMF is
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electrolytes [29].
3.1. UV–Vis spectra
The UV–Vis spectra of ligand (1) and its organotin(IV) com-
plexes (2–5) were carried out in CHCl3 (1  104 mol L1) at room
temperature. The electronic absorption spectrum of ligand (1)
showed three absorption bands at 262, 328 and 361 nm, corre-
sponding to the HOMO/LUMO transition of phenolic group, azome-
thine and thiolate function, respectively [30]. After complexation,
the complexes (2–5) showed four absorption bands at 264–269,
331–350, 382–385 and 404–416 nm, respectively. In the electronic
spectra of the complexes (2–5), the intraligand transition is shifted
to higher wavelength as a result of coordination. The new absorp-
tion at 404–416 nm, observed in the spectra of organotin(IV) com-
plexes (2–5), is assigned to ligand ? metal charge transfer (LMCT)
[31]. The shift of kmax from the ligand to the complexes is a clear
indication of coordination between tin(IV) ion and the ligand.
3.2. Infrared spectra
The free ligand (1) showed absorption bands at 3315 and
3202 cm1, which are due to the stretching vibrations of the OH
and NH groups, respectively. The CAH stretching vibrations of
cyclohexyl moiety were observed at 2923 and 2851 cm1. The
other bands observed in the spectrum at 1620, 1296, 987 and
1365, 840 cm1 due to m(C@N), m(CAO), m(NAN) and m(C@S),
respectively. Several significant changes with respect to the free
ligand (1) bands on complexation suggest coordination through
the phenolic group, azomethine and sulfur of the thiolic form of
the ligand. The strong stretching band at 3315 cm1 that corre-
sponds to the m(OH) group in the spectrum of ligand (1) has disap-
peared in the spectra of complexes (2–5) due to the deprotonation,
indicates metal–ligand bond formation through the site. The free
ligand (1) showed a band at 1296 cm1 which is due to m(CAO).
This band is shifted to lower wave numbers at 1261–1268 cm1
in the complexes (2–5), indicating the coordination of O to the ti-
n(IV) atom [32]. The newly formed m(C@NAN@C) bond showed
medium to strong absorption peaks within the range of 1595–
1598 cm1 in the spectra of the complexes (2–5), indicating coor-
dination of azomethine nitrogen to tin(IV) atom [33]. The
m(NAN) band of the free ligand at 987 cm1 is shifted to higher
frequencies at 1021–1028 cm1 in the spectra of organotin(IV)
complexes (2–5), again confirms the coordination of azomethine
nitrogen to the Sn(IV) atom [34]. The stretching and bending fre-
quency of the m(CAS)) band observed at 1365 and 840 cm1 in
the spectrum of the ligand (1) are shifted to lower frequencies at
1322–1347 and 822–827 cm1 in the spectra of the complexes
(2–5), indicating coordination of sulfur atom in the thiolate form
[35,36]. Characteristically one new band was observed at 543–
531 cm1 in the spectra of the complexes (2–5), suggesting the
presence of SnAO bonding in their structure. There are two new
bands at 598–600 and 420–447 cm1, respectively, tentatively as-
signed to m(SnAC) and m(SnAN). The IR observation indicated the
coordination of ligand (1) to the tin(IV) core of the complexes
(2–5) via phenoxide-O, azomethine-N and thiolato-S atoms. These
observations have also been confirmed by X-ray single crystal
structure analysis of complex 5.
3.3. 1H, 13C and 119Sn NMR spectra
The 1H NMR spectral assignments of ligand (1) and its organo-
tin(IV) complexes (2–5) were carried out and interpreted based on
the atom labeling in Scheme 2. 1H NMR spectrum of free ligand (1)
showed resonance signals at 10.89, 8.79, 8.35, 7.44–7.29, 2.35 and1.8 ppm due to OH, N2AH, CyC1AH, aromatic ring protons,
N@CACH3 and SH, respectively. The resonance signal of SH is not
found in the spectra of complexes (2–5) which suggested the
deprotonation of the SH proton and confirming that the ligand
coordinated to the Sn(IV) in the thiolate form. The OH proton signal
was also absent in the spectra of the complexes (2–5), suggested
deprotonation of the phenolic proton and supported the phenolic
oxygen atom was coordinated with tin(IV) atom. The azomethine
proton (N@CACH3) signal appears at 2.35 ppm in the free ligand
(1) which is shifted to downfield at 2.51–2.46 ppm in the com-
plexes (2–5). This downfield shift indicating the azomethine nitro-
gen atom is coordinated to tin (IV) atom [37]. The resonance
signals for the protons of phenyl moiety of the ligand (1) were ob-
served at 7.44–7.29 ppm, which also appeared in the up field re-
gion at 7.43–7.25 ppm in the complexes (2–5). This is due to the
electron withdrawal tendency from the aromatic ring owing to
coordination with tin(IV). The cyclohexyl moiety forms a chair con-
formation and hence the protons exist in axial and equatorial envi-
ronments. The equatorial protons 2.09–2.07 ppm are found to
resonate at a slightly higher field compared to that of the axial
protons 1.79–1.28 ppm in the ligand (1) and its organotin(IV) com-
plexes (2–5). The methyl group attached to the tin(IV) in complex
(2) give a singlet at 1.07 ppm with 2J[119Sn, 1H] coupling constant
value equal to 79.1 Hz, supported the five-coordinate environment
around tin(IV) [38]. The three butyl groups attached to the tin(IV)
moity in the organotin(IV) complex (3) gave four resonance signals
namely, 2.03–2.02 ppm (triplet, SnACH2ACH2ACH2ACH3), 1.65–
1.60 ppm (multiplet, SnACH2ACH2ACH2ACH3), 1.52–1.23 ppm
(multiplet, SnACH2ACH2ACH2ACH3) and 0.89–0.84 ppm (triplet,
SnACH2ACH2ACH2ACH3). 1H NMR information also supported
the IR data of the complexes (2–5).
The 13C NMR signals of the free ligand (1) were observed at
184.99, 164.11, 142.36–137.10, 48.83–32.61 and 8.99 ppm, due
to the d(NHAC@S), d(C@N), d(aromatic ring), d(cyclohexyl ring)
and d(CH3), respectively. After complexation, the carbon signals
of the N@CAS group shifted to up field at 181.10–179.22 ppm in
the complexes (2–5) in compared to the ligand (1), indicating par-
ticipation of the N@CAS group in coordination to tin(IV) atom. The
chemical shifts of carbon in C@N and CH3 in the free ligand (1)
were observed at 164.11 and 8.99 ppm which were shifted to
down field region at 174.45–164.11 and 18.10–15.88 ppm, respec-
tively, in the complexes (2–5), indicating the azomethine-N is
coordinated to the tin(IV) moiety. The d value of carbon atoms in
the cyclohexyl ring and aromatic ring did not have much change
in the complexes (2–5) as compared to the free ligand. The butyl
group attached to the organotin(IV) moiety in complex 3 gave four
resonance signals at 32.88, 26.32, 24.88 and 20.73 ppm. The sharp
signal attributed to the methyl group attached to the tin(IV) core
appeared at 12.59 ppm in complex 2.
119Sn NMR chemical shifts of the complexes (2–5) were
recorded in CDCl3 solution. 119Sn NMR spectroscopy gives signifi-
cant information to determine the coordination number around
the tin atom. The 119Sn NMR of all the complexes (2–5) shows only
one resonance signal in the range of 170.10 to 188.94 ppm. The
occurrence of 119Sn chemical shifts in these areas indicates
five-coordinated environment in organotin(IV) derivatives around
the central tin atoms [39,40].
3.4. X-ray crystallography diffraction analyses
Crystals suitable for X-ray diffraction studies of the diphenyl-
tin(IV) complex (5) were grown by slow evaporation of chloro-
form/methanol (1:1) at room temperature. The compound
crystallized into a monoclinic lattice with space group symmetry
P21/n with one molecule per asymmetric unit. The molecular struc-
ture of diphenyltin(IV) complex (5) with atom numbering scheme
Table 1


















Radiation type k (Å) MoKa
F(000) 1144
Crystal size (mm) 0.2168  0.0948  0.0723
Crystal color colorless
Scan range h () 3.5030–28.5104
Absorption coefficient (l) (mm1) 1.105
Maximum and minimum transmission 0.947 and 0.849
Goodness-of-fit (GOF) on F2 1.034
Data/restrains/parameters 5198/0/299
Final R indices [I > 2r(I)] R1 = 0.0315, wR2 = 0.0592
R indices (all data) R1 = 0.0417, wR2 = 0.0645
Table 2
Selected bond lengths (Å) and angles () of [Ph2Sn(dact)] (5).
Bond lengths (Å)
Sn1A–S13A 2.5026(7) N10A–N11A 1.384(3)
Sn1A–N10A 2.211(2) N10A–C8A 1.311(3)
Sn1A–O1A 2.0871(17) N11A–C12A 1.315(3)
Sn1A–C1B 2.141(3) N14A–C12A 1.334(3)
Sn1A–C1C 2.138(3) N14A–C15A 1.467(3)
S13A–C12A 1.761(3) C8A–C9A 1.500(4)
O1A–C2A 1.347(3) C8A–C7A 1.466(4)
Bond angles ()
O1A–Sn1A–S13A 157.76(5) C1B–Sn1A–N10A 125.57(9)
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1. Selected bond lengths and bond angles are given in Table 2. The
molecular structure of diphenyltin(IV) complex (5) was found to be
a distorted trigonal bipyramidal arrangement. The meridional
plane of the tin(IV) complex (5) is taken up by the azomethine
nitrogen (N10A) and two phenyl rings from the centre tin(IV). The
sum of the bond angles N10AASn1AAClC (117.32(10)),
C1CASn1AAC1B (116.81(11)) and C1BASn1AAN10A (125.57(9))
is 359.7 showing thiosemicarbazone moiety is in the same plane
of the Sn atom. The axial plane is composed of the enolic oxygen
(O1A) and the sulfur (S13A) atoms of the ligand. In diphenyltin(IV)
complex (5), the largest bond angle involving the tin(IV) atom was
O1AASn1AAS13A (157.76(5)), indicating strong deviation from
the ideal value of 180. The bond angle of O1AASn1AAN10A is
80.77(8) whereas the bond angle of N10AASn1AAS13A is
77.30(6); therefore the total of these two angles is 158.07 showing
deviation from the ideal value 180. Thus, the geometric results
support the tin(IV) complex (5) rendered distorted trigonal bipyra-
midal configuration. The Sn1AAN10A bond length is 2.211(2) Å
which is close to the sum of covalent radii of Sn and N (2.15 Å),
but is considerably less than the sum of the Van der Waals radii
(3.75 Å) [39], indicating azomethine nitrogen (N10A) was bonded
very firmly with the tin (Sn1A) atom. The Sn1AAO1A bond distance
is 2.08 Å which is almost similar to the covalent radii of tin and oxy-
gen (2.10 Å) [41], indicating enolic oxygen (O1A) is strongly coordi-
nated to the tin(IV) core. These bond lengths are comparable with
the published diphenyltin(IV) complex [Ph2Sn(2,6-pdc)] [42]. The
Sn1AAS13A bond distance is 2.5026 (7)Å which is close to the
sum of the covalent radii of tin and sulfur 2.42 Å [43], but much
smaller than the Van der Waals radii 4.0 Å [44], and reveals that
the S atom is coordinated to the Sn core in the thiolate form and also
indicated the formation of SnAS bond. The bond length of
Sn1AAC1C (2.138(3) Å) and Sn1AAC1B (2.141(3) Å) are slightly
shorter than the non-polar covalent radii of SnAC (2.17 Å) [41],
but the values are consistent with those reported in other diorgano-
tin(IV) complexes [45,46]. The bond distances C12AAS13A
(1.761(3) Å) and N10AAN11A (1.384(3) Å) were consistent with
single bonds, whereas a double bond character is evident in
C12AAN11A ((1.315(3) Å) and C8AAN10A (1.311(3) Å) bonds.Fig. 1. Molecular structure of [Ph2Sn(dact)] (5).
O1A–Sn1A–N10A 80.77(8) C1C–Sn1A–N10A 117.32(10)
O1A–Sn1A–C1B 89.88(9) C1C–Sn1A–C1B 116.81(11)
O1A–Sn1A–C1C 94.41(9) C1C–Sn1A–S13A 98.87(7)
N10A–Sn1A–S13A 77.30(6) C12A–S13A–Sn1A 94.52(9)
C1b–Sn1AS13A 99.81(8) C2A–O1A–Sn1A 118.13(18)3.5. Artemia cytotoxicity
A brine shrimp (A. salina) lethality bioassay was carried out to
investigate the preliminary toxicity of ligand (1) and its organo-
tin(IV) complexes (2–5). The A. salina toxicity of 1–5 compoundsFig. 2. Results of Artemia toxicity test of compounds 1–5.
Table 3








Antibacterial activitya of the free ligand (1) and its organotin(IV) complexes 2–5
(inhibition zone in mm).
Bacterium 1 2 3 4 5 R
Escherichia coli – 16 14 15 19 28
Staphylococcus aureus – 14 11 16 17 31
Enterobacter aerogenes – 12 – 11 21 32
Salmonella typhi – 15 10 17 23 26
a Concentration used: 2 mg/ml of DMSO, R = standard drug: doxycycline, dash
indicate inactivity.
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The ligand (1) has a higher LC50 value compared to all its organo-
tin(IV) complexes (2–5). From the results, it is evident that all
the organotin(IV) complexes displayed potent cytotoxic activity
against A. salina. The highest toxicity was shown by diphenyltin(IV)
complex (5) whose LC50 value is 9.87 ppm while the lowest toxicity
is shown by compound (3) whose LC50 value is 61.20 compared to
the free ligand (1). It is evident that bulky organo groups may
enhance the dissociation of the tin(IV) complex to form ionic
compounds and enhance the permeation of the compound through
the membrane cell [47].3.6. Antibacterial activity
The synthesized ligand (1) and its organotin(IV) complexes
(2–5) were screened against Escherichia coli, Staphylococcus aureus,
Enterobacter aerogenes and Salmonella typhi to assess their antibac-
terial activity. The results of the antibacterial studies are given in
Table 4. The free ligand (1) was found to be inactive against all
bacteria. The screening results exhibited that complexes (2–5)
showed higher activity against various bacteria but comparatively
lower activity than the reference drug. Based on the results, diphe-
nyltin(IV) complex (5) displayed higher antibacterial activity than
the monoorganotin(IV) complexes (2–4) against tested bacteria.
PhSn(IV) complex (4) shows enhanced activity compared to the
corresponding MeSn(IV) (2)/BuSn(IV) (3) complexes. Therefore,
changing the organotin(IV) groups must play a significant role in
these compounds growth inhibitory activity. In addition, the
increased antibacterial activity of organotin(IV) complexes (2–5)
can be explained on the basis of chelation theory. In organotin(IV)
complexes, on chelation the polarity of the tin ion will be reduced
to a greater extent due to the overlap of the substituted thiosemi-
carbazone ligand orbital and partial sharing of the positive charge
of the tin ion with donor groups. The activity might be due to the
increasing lipophilic nature of these complexes resulting from the
metal chelation. The electron delocalization in the chelate ring
increases the lipophilic character of the metals chelate. Therefore,
for the complexes studied in the present work, the results are
consistent with those reported data for the biological activities in
other organotin(IV) complexes [48]. It is suggested that antibacte-
rial activity of the organotin(IV) complexes (2–5) are due to either
killing the microbes or inhibiting their multiplication by blocking
their active sites [49].4. Conclusion
Four new organotin(IV) complexes of 2-hydroxyacetophenone-
N(4)-cyclohexylthiosemicarbazone have been reported and fully
characterized by UV–Vis, FT-IR, 1H, 13C and 119Sn NMR spectral
studies. The ligand (H2dact) exists in thione form in a solid state
but it takes on a thiol form when it is in solution. The results
obtained from the spectroscopic characterization support the
proposed five coordinated structures of the complexes (2–5).
X-ray crystallographic diffraction has revealed that complex 5 is
rendered into a distorted trigonal bipyramidal geometry. Biological
studies showed that all the organotin(IV) complexes (2–5) are
more potent antibacterial and cytotoxic agents than their free
ligand (1), while the diphenyltin(IV) complex (5) is more active
than the other organotin(IV) derivatives (2–4).
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